Internal dosimetry for systemic radiation therapy.

The key to effective use of the medical internal radiation dose (MIRD) schema in radioimmunotherapy (RIT) is to understand how it works and what the essential data input requirements are. The fundamental data are acquired from medical imaging. Image interpretation involves (1) collecting data to determine the source-organ activities, (2) plotting the source-organ time-activity curves, (3) integrating the time-activity curves for an estimate of the residence time, and (4) applying the residence time values (for each important source organ) within the MIRD schema to calculate the tissue absorbed dose to target organs and tumors of interest. This article reviews methods for calculating internal dose. It also describes methods for selecting sampling times, integrating the area under the data curves, and customizing a dose assessment for a patient who does not resemble the MIRD phantom. A sample dose assessment is given, together with common mistakes to avoid. Three approaches to red marrow dosimetry are described. With the increased use of RIT agents for cancer treatment, a solid understanding of internal dose methods is essential for treatment planning and follow-up evaluations.

[1]  David G. Cadena,et al.  Limits for Intakes of Radionuclides by Workers. ICRP Publication 30, Part 3 , 1983 .

[2]  W. S. Snyder,et al.  Estimates of absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom. , 1974, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  W E Bolch,et al.  MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions--radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  B. Wessels,et al.  MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  G T Chen,et al.  An overview of imaging techniques and physical aspects of treatment planning in radioimmunotherapy. , 1993, Medical physics.

[6]  J G Kereiakes,et al.  In vivo quantitation of lesion radioactivity using external counting methods. , 1976, Medical physics.

[7]  Thomas F. Budinger,et al.  MIRD primer for absorbed dose calculations , 1988 .

[8]  K. F. Eckerman,et al.  Specific absorbed fractions of energy at various ages from internal photon sources: 6, Newborn , 1987 .

[9]  C. W. Mays,et al.  Delayed Effects of Bone-Seeking Radionuclides , 1970 .

[10]  R. E. Lee,et al.  Sacral scintigraphy for bone marrow dosimetry in radioimmunotherapy. , 1989, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[11]  F. Spiers The influence of energy absorption and electron range on dosage in irradiated bone. , 1949, The British journal of radiology.

[12]  Icrp Radiation dose to patients from radiopharmaceuticals , 1988 .

[13]  M G Stabin,et al.  MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  Ws Snyder,et al.  MIRD Pamphlet #11: S, Absorbed Dose per Unit Cumulated Activity for Selected Radionuclides and Organs , 1975 .

[15]  P. Leichner,et al.  Tumor dosimetry in radioimmunotherapy: methods of calculation for beta particles. , 1993, Medical physics.